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Precis Mutations in the transmembrane Prominin 1 cause photoreceptor degeneration. By using 7	  
Prominin 1-deficient mice, we show that the degeneration is light dependent and is partially alleviated 8	  
by fenretinide. 9	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Abstract 1	  
 2	  
PURPOSE: Mutations in Prominin-1 (Prom1) gene are known to cause retinitis pigmentosa and 3	  
Stargardt disease, both of which are associated with progressive photoreceptor cell death. There are 4	  
no effective therapies for either disorder. The aim of this study was to investigate the mechanism of 5	  
the retinal degeneration in Prom1-deficient mouse models. 6	  
METHODS: We constructed Prom1 knockout mice with two distinct genetic backgrounds of C57BL/6 7	  
and C57BL/6xCBA/NSlc, and investigated the photoreceptor degeneration by means of histology and 8	  
functional tests. In addition, we examined the effect of light on the Prom1-/- retina by rearing the mice 9	  
in the normal light/dark cycle and completely dark conditions. Finally, we investigated if the retinoic-10	  
acid derivative Fenretinide slowed the pace of retinal degeneration in these mouse models.  11	  
RESULTS: The Prom1-/- knockout mice with both backgrounds developed photoreceptor degeneration 12	  
after eye opening, but the CB57/BL6 background mice developed photoreceptor cell degeneration 13	  
much faster than the C57BL/6xCBA/NSlc mice, demonstrating genetic background dependency. 14	  
Interestingly, our histological and functional examination showed that the photoreceptor cell 15	  
degeneration of Prom1 knockout mice was light dependent, and was almost completely inhibited when 16	  
the mutant mice were kept in the dark. The Prom1 knockout retina showed strong downregulation of 17	  
expression of the visual cycle components, Rdh12 and Abca4. Furthermore, administration of 18	  
Fenretinide, which lowers the level of the toxic lipofuscin, slowed the degeneration of photoreceptor 19	  
cells. 20	  
CONCLUSIONS: These findings improve our understanding of the mechanism of cell death in 21	  
Prominin1 related disease and provide evidence that fenretinide may be worth studying in human 22	  
disease.  23	  
 24	  
 25	  
 26	  
Short title: Genetic background and light dependent photoreceptor degeneration 27	  
Key words: Prominin1, retinitis pigmentosa, Stargardt disease, Fenretinide, photoreceptor 28	  
degeneration, light, modifier gene 29	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Introduction 1	  
 2	  
Prominin-1 (Prom1) (NCBI Gene ID 8842; also known as RP41, AC133, CD133, MCDR2, STGD4, 3	  
PROML1) encodes a 120 kDa pentaspan transmembrane glycoprotein [1], originally identified as a 4	  
surface antigen of human haematopoietic stem and progenitor cells [2]. Prom1 is expressed in a 5	  
number of tissues throughout embryogenesis and adulthood [1,3-6], and has been implicated in the 6	  
maintenance of stem cell characteristics and cell proliferation [6-14]. In addition to these functions, 7	  
Prom1 has been shown to be involved in a number of genetic disorders that cause photoreceptor 8	  
degeneration, including retinitis pigmentosa (RP; OMIM 268000; autosomal dominant and autosomal 9	  
recessive forms) and Stargardt's type 4 (STGD4; OMIM 603786) [15-17]. 10	  
 11	  
RP encompasses a genetically heterogeneous group of inherited disorders causing progressive 12	  
photoreceptor cell death [15,17] and affects about 1 in 4000 people. It usually starts with early rod 13	  
photoreceptor damage, manifesting as nyctalopia. Later there is loss of peripheral visual field, and in 14	  
advanced disease loss of central vision due to death of foveal cones. More than 60 causal genes have 15	  
been identified, including those encoding transcription factors, splicing regulators, membrane proteins 16	  
and proteins involved in visual cycle [17]. 17	  
 18	  
Stargardt’s disease is one of the macular dystrophies, which predominantly affect the central retina. 19	  
The most common form of the dystrophy, Stargardt's type 1 (STGD1; OMIM 248200) is an autosomal 20	  
recessive disorder that is characterized by macular atrophy with or without flecks at the level of the 21	  
retinal pigment epithelium [16,18] and has a prevalence of at least 1 in 10,000 births; it is usually 22	  
diagnosed in the first or second decade of life, [19,20] and is recognized as the most common cause 23	  
of macular disease in children. STGD1 is caused by mutations in the ATP-binding cassette, sub-family 24	  
A member 4 (ABCA4) gene (NCBI Gene ID 24; also known as RP19, ABCR) [21]. There are four 25	  
types of Stargardt’s disease known so far. Three other forms of macular dystrophy have some 26	  
phenotypic similarities to STGD1 but some of them show autosomal dominant inheritance; Stargardt's 27	  
type 2/3 (STGD2/3; OMIM 600110) caused by defects in the ELOVL Fatty Acid Elongase 4 (ELOVL4) 28	  
(NCBI Gene ID 6785) and Stargardt's type 4 caused by Prominin-1 (Prom1) genes [22-24], 29	  
respectively. Although there have been a number of different therapeutic approaches suggested [25], 30	  
there are as yet no effective treatments for this group of disorders. 31	  
 32	  
Mutations in Prom1 have been reported in both RP (autosomal dominant and autosomal recessive 33	  
forms) and STGD4 [15-17]. A homozygous frameshift mutation of Prom1 gene, causing a premature 34	  
termination of the translation, was found in an Indian pedigree and resulted in inherited retinal 35	  
degeneration [26]. A homozygous mutation resulting in a truncated PROM1 protein was identified in a 36	  
family with severe retinitis pigmentosa (RP), where affected patients reported night blindness and 37	  
decreased visual acuity in early childhood with subsequent severe loss of central vision in adult life 38	  
[27]. More recent reports have identified recessive mutations in PROM1 in patients with cone-rod 39	  
dystrophy [28,29]. In contrast to these autosomal recessive mutations, another mutation, 40	  
	   5	  
Prom1/R373C (the mutation where the 373rd Arginine residue was substituted with Cysteine), is 1	  
inherited as an autosomal dominant trait and causes STGD4 as well as bull’s eye macular dystrophy 2	  
(OMIM 608051) [24]. In this mutation, onset of Prom1 mediated STGD4 varies from 10 to 29 years old 3	  
with a mean age of 19 years. Thus, Prom1 is associated with a wide range of human retinal dystrophy 4	  
phenotypes; the disease severity can vary significantly even with individuals who harbor the same 5	  
disease causing mutation(s). 6	  
 7	  
Mouse models have been generated to recapitulate the retinal degeneration caused by PROM1. To 8	  
date, a transgenic mouse expressing the human PROM1/R373C [24] and a Prom1 knockout mouse 9	  
[30] have been established and both show retinal degeneration. In both models, the photoreceptor 10	  
layer (outer and inner segment layers) and the outer nuclear layer (ONL) start to degenerate at 11	  
postnatal day 15 (P15), and are absent by 12 months. [24,30]. 12	  
 13	  
It is notable that the onset and progress of the diseases vary in patients, even within a single family 14	  
[24,27,28,31,32]. Progression of the disease is rapid in some patients, but relatively slow in others. 15	  
The molecular mechanisms underlying the variation in progression of Prom1-mediated retinal 16	  
degeneration are however still largely unknown, but may reflect variation in environmental factors or 17	  
modifier genes. 18	  
 19	  
In this study, we have constructed new Prom1 knockout mice to recapitulate the haploinsufficient-type 20	  
of photoreceptor degenerative diseases [22,26]. We raised the mutant mice under distinct genetic 21	  
backgrounds, and found that they showed evidence of photoreceptor cell degeneration with a different 22	  
rate of progression. Using these models, we investigated the molecular mechanisms of the disease 23	  
phenotype. 24	  
  25	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Methods 1	  
 2	  
Animals and housing conditions  3	  
All animals in this study were subject to local and national ethical approval and guidance (University 4	  
College London Ethical Committee and UK Home Office Regulations for Animal Use; RIKEN CDB 5	  
Animal Care and Use Committee). 6	  
Two distinct genetic backgrounds (C57BL/6 and a hybrid of C57BL/6xCBA/NSlc) of Prom1 knockout 7	  
mice were analyzed. The generation of Prom1-deficient mice with C57BL/6 background (RIKEN 8	  
strain) has been previously reported [10], and the information has been deposited in the database of 9	  
RIKEN Center for Developmental Biology (http://www.cdb.riken.jp/arg/mutant mice list.html (accession 10	  
number: CDB0623K)). Due to breeding difficulties on this background, in vitro fertilization (IVF) using 11	  
Prom1 heterozygote sperm and eggs obtained from Wild Type CBA/NSlc mice was employed. The 12	  
resulting heterozygotic sperm and eggs were then used for the second IVF to obtain Prom1-/- mice. 13	  
The mice with both backgrounds were used for histological analyses (Figure 1A-E, 3A-E), whereas all 14	  
other experiments were performed only with the C57BL/6xCBA/NSlc background. Prom1-/- and 15	  
littermate controls were housed and maintained under standard laboratory conditions with a 12-hour 16	  
day (160-lux)–night cycle and ad libitum access to food and water.  17	  
Effect of Light on Prom1 retinal degeneration 18	  
For dark rearing (darkness luminescence <0.5 lx), female mice and their litters (P1 or P8) were 19	  
transferred into a ventilated housing cabinet (Scantainer I-110, Scanbur, Denmark), which was further 20	  
modified in house to reduce light exposure from the outside. Dark-housed animals were kept in the 21	  
cabinet for approximately 4 weeks before analysis. The extent of photoreceptor degeneration was 22	  
examined at P30. Electroretinograms (ERGs) were performed to assess retinal function. Mice were 23	  
subsequently culled and the eyes enucleated under dim red light and processed for paraffin sectioning. 24	  
Animal husbandry was performed under red light (emission spectrum above 600 nm, red lamp, 25	  
#02580, British Electrical Lamps Limited, UK).  26	  
Histology 27	  
Eyes were enucleated and fixed in 4% buffered paraformaldehyde (PFA, Sigma-Aldrich, Gillingham, 28	  
UK) in 1X PBS for 30 min at room temperature. To allow penetration of the fixative in adult eyes a 29	  
circumferential cut was made around the posterior margin of the ciliary body and only the posterior 30	  
eyecup was retained and fixed for another 30 min. Eyecups were processed with a series of 31	  
ascending alcohols; cleared in trichloromethane; then embedded in paraffin. Retina paraffin blocks 32	  
were cut sagittally at 5 µm thickness using a microtome Sections for hematoxylin and eosin (HE) 33	  
staining were first de-waxed in xylene, rehydrated, rinsed in water, and stained. The sections of the 34	  
central part of the eye were analysed, and the images were taken at the top part. 35	  
Electroretinography (ERG) 36	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Electroretinography (ERG) was performed using a ColorDome Ganzfeld ERG (Diagnosys LLC, 1	  
Cambridge, UK). Briefly, mice were dark-adapted overnight for scotopic measurements and 2	  
anesthetized under red light illumination by intraperitoneal injection of 50-75 mg/kg ketamine 3	  
(Narketan, National Veterinary Services Ltd, Stoke-on-Trent, UK) and 10% medetomidine (Domitor, 4	  
National Veterinary Services Ltd). Pupils were dilated using 10 mg/kg tropicamide and 0.5% 5	  
phenylephrine hydrochloride. Animals were kept on a heating mat throughout the procedure to 6	  
maintain the body temperature at 37°C. Subdermal needle electrodes (CareFusion, Middleton, WI, 7	  
USA) were inserted as ground and reference electrodes near the hindquarter and between the eyes, 8	  
respectively. Gold ring electrodes were placed on the corneal surfaces, which were lubricated using 9	  
carbomer gel (Viscotears, Novartis Pharmaceuticals, UK). Following a further 10 minutes of dark 10	  
adaptation the scotopic ERG was simultaneously recorded from both eyes with increasing stimulus 11	  
strengths using mixed white light from 10-5 cd.s/m2 to 10 cd.s/m2 with every 10-fold interval. Four 12	  
animals per genotype were analyzed in each set of experiments, 13	  
Immunohistochemistry 14	  
Following antigen retrieval (boiled in Tris-EDTA pH 9.0) sections were stained with either mouse 15	  
monoclonal anti-Rhodopsin (Sigma) diluted 1:500 or rabbit polyclonal anti M-opsin (Millipore) diluted 16	  
1:500. Secondary antibodies included goat anti-mouse Alexa Fluor 488® or goat anti-rabbit Alexa Fluor 17	  
488®. Images were collected with LSM 710 confocal microscope (Zeiss). 18	  
Treatment with fenretinide and A1120 19	  
Administration of fenretinide and A1120 was performed as described previously [33,34], with slight 20	  
modifications. Briefly, Prom1-/- mice (P0) were injected intraperitoneally three times a week with 10 21	  
mg/kg of Fenretinide (N-[(4-hydroxyphenyl)amino]retinal; also known as 4-HPR; CAS number 65646-68-22	  
6) or the equivolume of DMSO (Dimethylsulfoxide) for 4 weeks. A1120 (2-(4-(2-23	  
(trifluoromethyl)phenyl)piperidine-1-carboxamido)benzoic acid; CAS number 1152782-19-8) [35,36], an 24	  
RBP4 (NCBI gene ID 5950; Retinol Binding Protein 4) inhibitor, was tried at 30 mg/kg (see Discussion). 25	  
Treated mice were subject to the analyses two days after the last injection. 26	  
Quantitative RT-PCR (qRT-PCR) 27	  
Total RNA was isolated from whole eye samples using RNeasy mini kit (Qiagen, Crawley, UK) 28	  
following manufacturer’s instructions. Reverse-transcription was performed using Superscript II 29	  
Reverse Transcription Kit (LifeTechnologies). Real-time quantitative RT-PCR was performed with a 30	  
thermal cycler (7900HT; Applied Biosciences). Reagents were obtained from Applied Biosystems and 31	  
all primers were designed to span an intron to avoid amplifying genomic DNA. 18S was used as the 32	  
internal control. The primer sequences are available in Supplementary Table 1. PCRs were conducted 33	  
using at least three separate RNA preparations. 34	  
Electron microscopy 35	  
	   8	  
Eyes were enucleated and fixed in 3% glutaraldehyde and 1% paraformaldehyde in 0.08 M sodium 1	  
cacodylate-HCl (pH 7.4) for at least 30 h at 4 °C. The cornea and lens were removed and the eye 2	  
cups oriented and post-fixed in 1% aqueous osmium tetroxide for 2 h, dehydrated by an ascending 3	  
ethanol series (50%–100%) and propylene oxide, and infiltrated overnight with a 1:1 mixture of 4	  
propylene oxide and araldite resin (Agar Scientific Limited, Essex UK). After 8 h in full resin, the eyes 5	  
were embedded in fresh resin and incubated overnight at 60 °C. Semithin (0.7 µm) sections were cut 6	  
in the inferior–superior axis passing through the optic nerve head with a microtome (Ultracut S; Leica, 7	  
Wetzlar, Germany) Ultrathin sections were collected on copper grids (100 mesh, Agar Scientific), 8	  
contrast-stained with 1% uranyl acetate and lead citrate and analyzed using a JEOL 1010 9	  
transmission electron microscope at 80 kV. Retinal sections from three animals per genotype were 10	  
analysed. 11	  
Statistics 12	  
Electroretinogram (ERG) results were compared using two-way ANOVA on GraphPad Prism V4 13	  
(GraphPad software) with p-values of < 0.05 considered statistically significant. 14	  
  15	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Results 1	  
 2	  
Prom1 knockout mice develop photoreceptor cell degeneration in a genetic background 3	  
dependent manner 4	  
In order to examine the mechanism of Prom1 mediated photoreceptor degeneration, we originally 5	  
made a Prom1 deficient mouse with pure C57BL/6 background [10], in which the wild type does not 6	  
develop any degeneration or have retinal abnormalities (Figure 1A,B). At postnatal day 14 (P14), the 7	  
layered structure, morphology of retinal neurons and glial cells, in particular morphology of the 8	  
photoreceptor outer segment, and the numbers of retinal cells, showed that the retina was normal 9	  
(Figure 1C,E). In contrast, at P20 the photoreceptor cell layer including the outer segment and cell 10	  
body was completely missing (Figure 1D,E). Thus Prom1-knockout mouse developed photoreceptor 11	  
cell degeneration (Figure 1C-E) as observed in the previously reported Prom1 knockout mice [30]. 12	  
 13	  
Due to the fact that C57BL/6 background Prom1-/- mice have difficulty in breeding, we generated the 14	  
same Prom1-targeted mice with a hybrid background of C57BL/6xCBA/NSlc (see Material and 15	  
Methods). This new knockout also started to exhibit extensive photoreceptor outer segment 16	  
degeneration after P14 (Figure 1F,J,N), which coincided with eye opening. However, at P20, in contrast 17	  
with the Prom1-/- mice on the C57BL/6 background (Figure 1D,E), the outer plexiform layer (OPL), the 18	  
outer nuclear layer (ONL) and outer/inner segments (OS/IS) were still preserved with thickness of 74%, 19	  
76% and 61%, respectively, compared to the wild-type mice (Figure 1G,K,N). This unexpected result 20	  
prompted us to analyze the progression of the photoreceptor degeneration chronologically. The Prom1-/- 21	  
mice with C57BL/6xCBA/NSlc at P30 showed a substantial degree of retinal degeneration with 22	  
approximately 22% of photoreceptor nuclei remaining (Figure 1H,L,N). By 4 months (P120) the entire 23	  
ONL and OS/IS had been completely abolished (Figure 1I,M,N). On the other hand, the inner nuclear 24	  
layer (INL) and inner plexiform layer (IPL) were largely unaffected (Figure 1I,M,N). 25	  
 26	  
These histological observations suggest that PROM1 is essential for the maintenance, rather than the 27	  
development of retinal structure, and the phenotype with Prom1 deficiency is dependent on the genetic 28	  
background. 29	  
 30	  
Expression of rhodopsin and M-opsin in the photoreceptor cells is downregulated and misplaced 31	  
in Prom1-deficient mice. 32	  
We further analysed the ultrastructure of the Prom1-/- in C57BL/6xCBA/NSlc retinal cells by using 33	  
transmission electron microscopy (TEM). At P20, the photoreceptor outer segments of the retina were 34	  
severely shortened in the Prom1-/- mice compared to that of wild-type (Figure 2A,B), which is 35	  
consistent with the histological findings (Figure 1K). 36	  
 37	  
In the C57BL/6xCBA/NSlc mice, P20 is the beginning stage of the photoreceptor degeneration, and 38	  
this enabled us to observe the intermediate stages of the degeneration. The tight junction structure at 39	  
the outer limiting membrane seemed to be largely intact in the Prom1-/- retina (Figure 2C,F; red 40	  
	   10	  
arrowheads)	   [37], and the mitochondria were formed normally in the inner segment (Figure 2D,G; red 1	  
arrowheads). However, the structure of the outer segment was severely disorganized and misaligned 2	  
(Figure 2E,H). This was consistent with the previous observation in the mice with the different genetic 3	  
background [30]. 4	  
 5	  
We next examined the expression of photoreceptor specific proteins in the Prom1 knockout by 6	  
immunohistochemistry. At P20, WT retina showed a strong signal of the G-protein coupled receptor 7	  
(GPCR) rhodopsin correctly localized to the outer segment in the rod photoreceptor (Figure 2I,I’). In 8	  
contrast, in the Prom1-/- retina, the signal was found in the inner segments and in the outer nuclear 9	  
layer (Figure 2J,J’)	   [30]. In addition, another GPCR M-opsin, normally localized to the outer segment 10	  
of cone photoreceptors (Figure 2K,K’) [38], was largely missing in Prom1-/-, and was partially found in 11	  
the outer nuclear layer, with the occasional cells showing positive signal (Figure 2L,L’).  12	  
 13	  
Taken together these observations demonstrate Prom1 is required for the maintenance of both rod- 14	  
and cone- photoreceptor cells, and for the correct localization of opsin proteins that act in the outer 15	  
segments. 16	  
 17	  
Light-dependent impairment of photoreceptor cells in the Prom1-deficient mice 18	  
The photoreceptor degeneration in both mice strains of the pure C57BL/6 background and on the 19	  
C57BL/6xCBA/NSlc background was initiated after P14, when they open their eyes. We thus 20	  
hypothesized that Prom1 mediated photoreceptor degeneration was triggered by light exposure.  21	  
 22	  
In order to examine the effect of light on the photoreceptor degeneration in Prom1 knockout mice, the 23	  
C57BL/6 mice were reared in complete darkness and compared with mice kept under normal light-dark 24	  
cycle (see Material and Methods for details). At P30, the Prom1-/- kept under normal light cycle indeed 25	  
had no photoreceptor cells (OS,IS,ONL in Figure 3A,B). In contrast, the animals reared under the dark 26	  
conditions still had some photoreceptor cells remaining, and their outer segments of comparable length 27	  
to the wild type control (Figure 3C,D). Similar observations were made in the Prom1-/- mice with the 28	  
C57BL/6xCBA/NSlc background (Figure 3E-H); the Prom1-/- mice reared under the normal light-dark 29	  
cycle developed a severe photoreceptor degeneration (Figure 3E,F), while the same Prom1-depleted 30	  
animals under the dark condition retained a significant proportion of the photoreceptor layer (Figure 31	  
3G,H). These observations suggest that the photoreceptor degeneration in Prom1-knockout mice 32	  
developed in a light dependent manner both in C57BL/6 and C57BL/6xCBA/NSlc backgrounds. 33	  
 34	  
We further analyzed the ultrastructure of the photoreceptor cells by transmission electron microscopy 35	  
(TEM). The outer segment of the Prom1-/- retina reared under dark conditions partially retained the 36	  
structure of the cells (Figure 3I-L, compared to Figure 2B,F-H). In addition, as examined by 37	  
immunohistochemistry in the Prom1-/- mice, less mislocalized signal of rhodopsin and M-opsin staining 38	  
was found in the inner segments compared to those under the light/dark condition (Figure 3M-O, 39	  
	   11	  
compared to Figure 2J,J’,L,L’). Together these observations indicate that the Prom1-/- photoreceptor cell 1	  
structure can be retained when the retina is protected from light. 2	  
 3	  
We next investigated the function of photoreceptor cells in the C57BL/6xCBA/NSlc Prom1-/- mice. To 4	  
this end, we examined the a and b waves of the electro-retinogram (ERG). ERG is conducted to 5	  
measure the electrical responses of the retinal cells upon external stimuli, and may be used to 6	  
evaluate progression of retinal diseases [39]. An ERG consists of two peaks; the initial peak (a-wave; 7	  
Figure 4A) reflects the physiological health of the rod or cone photoreceptors and the second (b-wave; 8	  
Figure 4A), the inner layers of retina, including bipolar, amacrine and Müller cells [40]. We performed 9	  
both scotopic (Figure 4A-F) and photopic (Figure 4G,H) ERGs to investigate the function of rod and 10	  
cone photoreceptors, respectively. 11	  
 12	  
First we performed scotopic ERGs on the P30 mice (C57BL/6xCBA/NSlc) reared under the normal 13	  
light/dark condition. The Prom1-/- mice showed marked impairment of a- and b-waves (Figure 4C and 14	  
red lines in Figure 4E,F).  15	  
 16	  
We next performed scotopic ERGs on the Prom1-/- mice raised under complete darkness during the 17	  
period between P8 and P30. Strikingly, the a-wave and b-wave of the scotopic ERG in the dark-reared 18	  
Prom1-/- mice were significantly improved compared to those reard in the normal light/dark condition, 19	  
and the b-wave reached almost the same level as that of the wild-type retina (Figure 4E,F; blue lines). 20	  
The amplitudes of a- and b-waves in the dark-reared wild-type mice appeared to be the same as those 21	  
in the wild-type mice reared in the normal light/dark cycle, suggesting that the light stimulation per se 22	  
did not influence the condition of the wild-type retina (Figure 4A,B,E,F; black and green lines). Taken 23	  
together, this set of analysis demonstrated that Prom1-/- photoreceptor cells are functionally impaired 24	  
upon light exposure. 25	  
 26	  
We additionally performed photopic ERGs. In agreement with the scotopic ERGs, the amplitudes of 27	  
both a-waves and b-waves in the photopic ERGs were reduced in the Prom1-/- mice reared under the 28	  
normal light/dark cycle, but maintained if the knockout mice were protected from the light exposure 29	  
(Figure 4G,H). 30	  
 31	  
Altogether these structural and functional examinations indicate that photoreceptor cells in the Prom1-/- 32	  
mice are very vulnerable to light and damaged in a light dependent manner. 33	  
 34	  
Expression of genes involved in the visual cycle is affected in the Prom1 knockout mice 35	  
Light-dependent retinal degeneration is caused by a number of factors (see [41] and [42] for reviews). 36	  
Since some of these (e.g. Abca4, Rdh8, Rpe65, rhodopsin) are highly associated with the visual cycle, 37	  
we investigated the effect of the Prom1 gene knockout on the visual cycle.  38	  
 39	  
	   12	  
The visual cycle is a process which maintains the levels of the chromophore in photoreceptor outer 1	  
segments [16]. Phototransduction starts with the conversion of 11-cis-retinal into all-trans-retinal on 2	  
exposure of the photoreceptors to light. The all-trans-retinal is then recycled initially in the 3	  
photoreceptors and later in the RPE (retinal pigmented epithelium) cells to reform 11-cis-retinal. All-4	  
trans-retinal is first reduced to all-trans-retinol (Vitamin A), a process which requires ABCA4 5	  
[19,43,44], RDH12 [44-47] and RDH8 [44]. All-trans-retinol is then transported with IRBP to the RPE 6	  
cells, where it is converted, with the aid of LRAT to all-trans-retinyl-ester and further to all-trans-retinol 7	  
with the help of the isomerase RPE65. This all-trans-retinol is oxidized into 11-cis-retinal by RDH5/11 8	  
and is transported back to the rod cells with IRBP, where it forms a complex with rhodopsin (reviewed 9	  
in [16,48,49]). 10	  
 11	  
In order to investigate how Prom1 is involved in this visual cycle, we examined the expression of 12	  
visual cycle genes in PROM1-deficient mice. We isolated the eyes from the P14 wild-type or Prom1-/- 13	  
mice and performed qRT-PCR analysis. Expression of Abca4 and Rdh5/12/14 was significantly 14	  
reduced in the Prom1-/- retina. In contrast, the expression of rhodopsin, IRBP, LRAT, S-opsin, Rdh11 15	  
and Rdh13 were not significantly reduced compared to that in the wild-type tissue, whilst M-opsin was 16	  
rather upregulated (Figure 5). This data suggests that PROM1 is required for the maintenance of the 17	  
expression levels of Abca4 and Rdh12, and is consistent with the idea that PROM1 is involved in the 18	  
regulation of the visual cycle, especially at the reducing step of all-trans-retinal to all-trans-retinol.  19	  
 20	  
Fenretinide can partially prevent the photoreceptor degeneration 21	  
Failure of the reduction of all-trans-retinal to all-trans retinol results in the formation of all-trans retinal 22	  
dimer and A2E (a lipofuscin fluorophore; also known as N-retinylidene-N-retinylethanolamine) [48,50-23	  
53], both of which induce inflammation and subsequent photoreceptor cell dysfunction. The 24	  
accumulation of these compounds has been observed in Abca4-/-, Rdh8-/- and Rdh12-/- mice [33,44,53-25	  
55]. 26	  
 27	  
The synthetic retinoid derivative Fenretinide reduces the availability of retinoids to the eye by its 28	  
interaction with RBP [33] (Retinol Binding Proteins; RBP1-4; NCBI gene IDs 5947-5950) [56,57] and 29	  
thereby reduces accumulation of A2E in retinal pigment epithelium. As Fenretinide has been 30	  
investigated in animal models of Abca4-mediated Stargardt diseases [33,34,58], we investigated 31	  
whether Fenretinide may also reduce photoreceptor cell death in Prom1-/- mice.  32	  
 33	  
First, we examined the effect of Fenretinide on the Prom1-/- mice. We injected 10 mg/kg of Fenretinide 34	  
3 times a week from P0 for four weeks. At P30, compared to the vehicle injected control, Fenretinide 35	  
injected Prom1-/- mice had thicker photoreceptor segments and ONL, and increased number of 36	  
photoreceptor nuclei (Figure 6A-E). A similar result was obtained with a higher dosage (20 mg/kg) of 37	  
Fenretinide (unpublished data). This finding suggests that Fenretinide protected, at least in part, the 38	  
photoreceptor cells from Prom1-deficient mediated degeneration. 39	  
 40	  
	   13	  
Next we evaluated the effect of Fenretinide on the function of Prom1-/- retina by examining the 1	  
scotopic ERG responses. One caveat in this examination is that Fenretinide induces night-blindness 2	  
as a side-effect, because the function of rhodopsin is partially blocked and the visual cycle is slowed 3	  
down [34]. Consistently, the a-wave amplitude was decreased in the Fenretinide-treated retina (Figure 4	  
6F; gray line) compared to the non-treated retina (Figure 6F; black line), indicating that rod function is 5	  
affected by Fenretinide. In contrast, in the Prom1-/- retina, which were almost insensitive to the 6	  
stimulus unless treated (Figure 6G, black line), the rod responses were improved when treated with 7	  
Fenretinide (Figure 6G, red line). This effect was more evident when the results (Figure 6F,G) were 8	  
replotted against the control (DMSO-treated) retina as the reference (Figure 6H). This observation 9	  
suggests that Fenretinide despite its inhibitory effect on normal rod cells function improves rod 10	  
function in Prom1-/- mice possibly by reducing cell death. Likewise, the b-waves were decreased 11	  
(Figure 6I,K) when Fenretinide was treated in wild-type retina, but were improved in the Prom1-/- retina 12	  
upon treatment with Fenretinide (Figure 6J,K).  13	  
 14	  
Together the analyses indicate that the treatment with Fenretinide maintains the structure of 15	  
photoreceptor cells, which is accompanied by a partial recovery of function. 16	  
  17	  
	   14	  
Discussion 1	  
 2	  
Genetic background influences the progression of photoreceptor degeneration 3	  
This study demonstrates that variations in the genetic background significantly influence development of 4	  
photoreceptor cell degeneration mediated by knockout of the Prom1 gene. We examined the mutants 5	  
with two genetic backgrounds; a pure C57BL/6 and a hybrid C57BL/6xCBA/NSlc. The Prom1-/- mice of 6	  
the pure C57BL/6 background exhibited complete photoreceptor degeneration within one week after 7	  
eye opening (P20), while the retinal degeneration in the C57BL/6xCBA/NSlc mice developed much 8	  
more slowly (Figure 1). The same mouse strain showed the same degeneration profile, suggesting 9	  
that the variations in photoreceptor degeneration seem to be dependent on the genetic background, 10	  
rather than the individual mice. Variations in disease severity are reported in patients with retinal 11	  
disease caused by both autosomal-recessive (AR) [26,28,29] and autosomal-dominant (AD) Prom1 12	  
mutations [32]. Mouse knockout models are good models for human disease caused by AR Prom1 13	  
mutations but are not as useful as for studying the mechanism of AD disease. However it is possible 14	  
that environmental or genetic modifiers may be common to both types of disorder. 15	  
 16	  
A number of factors, both environmental and genetic, may account for this variation. In contrast to the 17	  
studies in man, the environmental factors can be carefully controlled in experimental studies in mouse 18	  
models; the mice used in our experiments were reared under carefully standardized conditions. 19	  
Therefore, most of the variation in the progression of the photoreceptor degeneration is likely to be 20	  
due to the genetic factors. The mechanisms underlying these strain differences are unknown and their 21	  
identification will be challenging. The two types of the mice used in our experiments will be a good 22	  
model system to identify such genetic factors for making this variation. 23	  
 24	  
It should also be noted that there is diversity even in the same genetic background [30]. The 25	  
previously reported Prom1-/- mice with the same C57BL/6 background started the degeneration 26	  
around P14, but even after 6 months the mice still had some remaining photoreceptor cells [10,30], 27	  
which is much slower than our knockout mice with the same C57BL/6 background employed in our 28	  
study (Figure 1A-E). This may be due to minor genomic variations raised by the difference of the 29	  
mouse source	   [30]. More detailed study of these various mouse models will help identify these 30	  
presumed genetic modifiers. 31	  
 32	  
The divergence of the severity in the mutant has been defined as “expressivity” [59-61]. It has been 33	  
suggested that expressivity is caused by modifier genes, which quantitatively influence the effect of the 34	  
loss of the targeted gene. In the case of Prom1, Abca4 and Rdh12 may play such roles. This view is 35	  
supported by the fact that the severity of light induced photoreceptor damage is dependent on the 36	  
expression level [62] or genetic polymorphisms [63,64] of the Rpe65 gene. Further work is needed to 37	  
identify the modifier gene(s) for Prom1, including the investigations of genomic variation, for example 38	  
SNP (Single-nucleotide polymorphism) and epigenetic status of the genomes in the different 39	  
individuals or genetic backgrounds. 40	  
	   15	  
 1	  
Light-dependent photoreceptor degeneration in Prom1-mutant mice and possible therapies for 2	  
Prom1-causing diseases 3	  
It has been shown that STGD1 patients are sensitive to light, and undergo light-protective treatments 4	  
[65]. This is consistent with the light-dependent photoreceptor degeneration found in the Prom1-/- mice, 5	  
raising the possibility that Prom1 is involved in the visual cycle function. Our qRT-PCR analysis 6	  
revealed the reduction of Abca4 and Rdh12 expression at the onset of the photoreceptor 7	  
degeneration, both of which are involved in the visual cycle (Figure 5). These two genes may therefore 8	  
be downstream targets of Prom1. An alternative possibility is that Prom1 mutant cells start to 9	  
degenerate first, and Abca4 and Rdh12 expression is downregulated as a secondary effect of 10	  
photoreceptor cell death. We would favor the former possibility, as the reduction of Abca4 and Rdh12 11	  
was highly selective – Abca4 and Rdh12 are downregulated whereas expressions of other genes were 12	  
unchanged (Figure 5) – suggesting that the gene regulation by PROM1 is independent of the 13	  
photoreceptor degeneration. 14	  
 15	  
How does PROM1 control the expression of these genes? As PROM1 is a transmembrane protein, 16	  
PROM1 may transduce the extracellular information or stimulation intracellularly. Future transcriptome 17	  
studies will provide systematic information about downstream target genes and possible upstream 18	  
regulatory pathways. 19	  
 20	  
Accumulation of all-trans-retinal dimer and A2E has been reported in the STGD1 model mice with 21	  
mutations of Abca4 [51,66,67]. A2E is the major fluorophore of lipofuscin and high levels of lipofuscin 22	  
are seen on fundus autofluorescence imaging in patients with Stargardt disease. As Prom1 deficiency 23	  
in our mouse models results in downregulation of Abca4 and Rdh12 gene expression, it is likely that 24	  
ensuing effects on the visual cycle will lead to accumulation of lipofuscin such as all-trans-retinal dimer 25	  
and A2E in the Prom1-/- mutants, although the direct measurement is yet to be performed. 26	  
 27	  
Fenretinide, originally recognized as an anti-cancer drug and later applied to retinal disease [68,69], 28	  
has been investigated in mouse models of STGD1 disease	   [36]. The potential human use of 29	  
Fenretinide will depend on the balance between the benefit (desired effect) to inhibit the accumulation 30	  
of the toxic lipofuscin	   [56,57], and the systemic and ocular side effects. Fenretinide use in animal 31	  
models (Figure 6F,H,I,K, Supplementary Figure S2A,C) [70], and in man [71] leads to rod dysfunction. 32	  
On the other hand, the Prom1-mutant mice treated with Fenretinide showed improved retinal structure 33	  
(Figure 6A-E) and improved scotopic ERG (Figure 6G,H,J,K) indicating that the positive effect on 34	  
photoreceptor degeneration outweighed the inhibitory effect on rod function.  35	  
 36	  
However, the recovery of the photoreceptor function from our fenretinide treatment experiments still 37	  
needs to be improved. In particular, the photopic ERG responses were not significantly improved by 38	  
fenretinide (Supplementary Figure S2). One of the possibilities for this limitation is the method of 39	  
administration. Recent studies have shown fenretinide has very poor oral bioavailability due to low 40	  
	   16	  
solubility and low permeability [72-74]. Therefore, for ocular diseases, a controlled-release formulation, 1	  
which provides drug release over a longer period of time, may be advantageous [75]. We have tried 2	  
another RBP binding compound A1120, which has been used in STGD1 mouse models [35,36]. The 3	  
drug was however, less effective than Fenretinide, (MD and SO; unpublished data). As some primary 4	  
amines and GPCR/adenylate cyclase inhibitors have recently been introduced to improve the 5	  
photoreceptor survival in Abca4-/- ; Rdh8-/- mice [48,76], it would be interesting to explore their effects 6	  
in Prom1-/- mice. 7	  
 8	  
In addition to its effect on the visual cycle, it has also been shown that PROM1 interacts with 9	  
Protocadherin-21 (NCBI Gene ID; 92211; PCDH21, CDHR1)	   [24,77], which has also been implicated in 10	  
the photoreceptor degeneration [78]. The systematic identification of PROM1-interacting proteins will 11	  
help to better understand the direct function of PROM1. 12	  
 13	  
In conclusion, we have provided evidence of light-dependent photoreceptor degeneration in the Prom1-/- 14	  
mice, and have identified possible downstream signaling targets. Further investigation of the 15	  
downstream target genes and interacting proteins will allow a better understanding of the mechanisms 16	  
of photoreceptor cell death and more targeted therapeutic approaches in the future. 17	  
 18	  
 19	  
 20	  
 21	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Figure Legends 1	  
Figure 1 Outer cell retinal layers progressively degenerate in the Prom1-deficient mice in a 2	  
genetic background dependent manner. (A-E) Photoreceptor and ONL areas are completely 3	  
obliterated within 20 days after birth in Prom1-/- mice with a C57BL/6 background (RIKEN strain). 4	  
Hematoxylin and Eosin (HE) staining was performed on retinal sections of wild type (A,B) or Prom1-/- 5	  
(C,D) mice at 14 days (P14) (A,C) and 20 days (P20) (B,D) after birth. Scale bar in (A-D) = 25 µm. 6	  
Relative size of each area in the Prom1-/- to the wild-type is shown in (E). n=3 for each genotype. (F-7	  
N) HE staining of Prom1-/- mice retina with a mixed background of C57BL/6xCBA/NSlc. Wild-type (F-I) 8	  
and Prom1-/- (J-M) mice retina with a mixed C57BL/6xCBA/NSlc background retinal sections at P14 9	  
(F,J), P20 (G,K), P30 (H,L) and P120 (I,M). Scale bar in (F-M) = 25 µm. (N) Relative size of each 10	  
retinal cell layer in the Prom1-/- mice compared to the wild-type mice. n=3 for each genotype. In (E) 11	  
and (N), the data are represented with the mean value ± s.e.m. Asterisks; statistically significant (p-12	  
value less than 0.05). OS; outer segment, IS; inner segment, ONL; outer nuclear layer, OPL; outer 13	  
plexiform layer, INL; inner nuclear layer, IPL; inner plexiform layer, **; degenerated area. 14	  
 15	  
Figure 2 The outer segments of the photoreceptor cells are disordered and Opsin proteins are 16	  
mislocalised in Prom1-deficient mice. (A-H) Outer segments are disorganized, while other parts of 17	  
the photoreceptor cells are largely intact at P20. Wild-type (A,C-E) and Prom1-/- mice retinae (B,F-H) 18	  
were analyzed by transmission electron microscope. (A,B) Panorama images of wild-type (A) and 19	  
Prom1-/- (B) photoreceptor cells. Note that these are merged images from several individual shots. 20	  
Original toluidine blue stained images are available in Supplementary Figure S1. RPE; Retinal 21	  
Pigment Epithelium. (C-H) Detailed structure of outer segments in the wild-type (C-E) and in the 22	  
Prom1-/- (F-H) retina was analyzed at the levels labeled in (A) and (B). Tight-like junctions at the 23	  
border of ONL and IS (red arrowheads in C,F), mitochondrial structure in IS (red arrowheads in D,G) 24	  
and the OS structure (E,H) are shown. Scale bar in (A,B) = 2 µm and (C-H) = 500 nm. (I-L’) Rhodopsin 25	  
and M-opsin proteins are mislocalized in the Prom1-/- retina. Wild-type (I,I’,K,K’) and Prom1-/- retina 26	  
(J,J’,L,L’) of P20 were analyzed by immunohistochemistry using rhodopsin (green in I,I’,J,J’) and M-27	  
opsin (green in K,K’,L,L’) antibodies. Ectopic localization is shown with brackets (I-J’) and with 28	  
arrowheads in (L,L’). DAPI is shown in blue (I’,J’,K’,L’). Scale bar in (I) = 100 µm for (I-L’). PR; 29	  
Photoreceptor Layer. 30	  
 31	  
Figure 3 Retinal degeneration in Prom1-knockout mice is light dependent. Both C57BL/6 (A-D) 32	  
and C57BL/6xCBA/NSlc (E-H) retinae were significantly protected from the photoreceptor 33	  
degeneration when the animals were reared in dark conditions. Wild-type littermate controls (A,C,E,G) 34	  
and Prom1-/- (B,D,F,H) mice (C57BL/6xCBA/NSlc) were reared under normal light (A,B,E,F) or 35	  
complete darkness (C,D,G,H) conditions from P8 until P30. Scale bar in (A-H) = 50 µm. (I-L) 36	  
Ultrastructural analysis by transmission electron microscopy. The C57BL/6xCBA/NSlc animals were 37	  
reared as in (H) and fixed at P30. Scale bar = 2 µm. Detailed structure at the levels denoted in (I) is 38	  
shown in (J-L). Mitochondia (red arrowhead in K) and tight-like junctions (red arrowheads in L) are 39	  
	   18	  
shown. Scale bar = 500 nm. (M-N’) The misocalization of rhodopsin (green in M,M’) and M-opsin 1	  
(green in N,N’) was reduced in the dark-reared mice. The Prom1-/- animals were reared in the dark 2	  
condition and analyzed by immunohistochemistry. DAPI is shown in blue in (M’,N’). Scale bar in (M) = 3	  
100 µm for (M-N’). (O) Quantification of the cells in which rhodopsin and M-opsin are mislocalized to 4	  
ONL. Several squares of 100 µm x 100 µm were randomly chosen within the IS and ONL and the 5	  
numbers of the positive cells for each protein were counted. The data of the wild-type and Prom1-/- 6	  
mice reared in the normal light-dark conditions were collected from Figure 2I-L’. The data are 7	  
represented with the mean value ± s.e.m. Three retinal tissues for each were analysed. Asterisks; 8	  
statistically significant (p-value less than 0.05). 9	  
 10	  
Figure 4 Prom1-/- mice show maintained their photoreceptor function when reared in dark. (A-D) 11	  
Representative recordings of scotopic ERG responses (a-waves (light blue in A) and b-waves (orange 12	  
in A)). C57BL/6xCBA/NSlc wild-type littermate (A,B) or Prom1-/- mice (C,D) reared under the normal 13	  
light/dark condition (A,C) or in the complete darkness from P8 until P30 (B,D) were subject to ERG 14	  
using seven light amplitudes within the range of 10-5 and 101 (cd.s.m-2) under scotopic conditions. 15	  
(E,F) Recordings of a-waves (E) and b-waves (F) from the wild-type under the normal light/dark (black 16	  
lines and circle dots; n=5) or the dark (green lines and circle dots; n=6), Prom1-/- under the normal 17	  
light/dark (red lines and rectangular dots; n=8) or the dark (blue lines and triangular dots; n=3) 18	  
conditions were summarized. Note that the horizontal axes are displayed in logarithmic scale. (G,H)  19	  
 20	  
Figure 5 Prom1 is essential for the expression of some of the visual cycle-related genes. The 21	  
relative expression levels of the indicated genes were analyzed by qRT-PCR analysis. qRT-PCR was 22	  
performed for C57BL/6xCBA/NSlc wild-type and P14 Prom1-deficient retina. The expression level of 23	  
each gene in the wild type retina was defined as 1. Three retinal tissues were analysed. Primer 24	  
sequences are indicated in Supplementary Table S1. 25	  
 26	  
Figure 6 The visual cycle inhibitor Fenretinide delays PROM1 mediated retinal degeneration, 27	  
and the retinal functions are partially preserved. C57BL/6xCBA/NSlc wild-type (A,B) or Prom1-/- 28	  
(C,D) mice treated with DMSO (vehicle) (A,C) or Fenretinide (B,D) were analysed at P30. Scale bar 29	  
(A) = 50 µm for (A-D). (E) Quantification of the photoreceptor nuclei in the ONL. (F-K) Fenretinide 30	  
treatment shows an improvement of the ERG response. Responses of a-waves (F-H) and b-waves (I-31	  
K) were recorded under scotopic conditions in the wild-type retina treated with control DMSO (black 32	  
lines and circle dots in F,I; n=5) or Fenretinide (FEN; gray lines and rectangle dots in F,I; n=3) and 33	  
Prom1-/- retina treated with control DMSO (black lines and circle dots in G,J; n=4) or Fenretinide (FEN; 34	  
red lines and rectangle dots in G,J; n=3). (H,K) The relative ERG scores upon the Fenretinide 35	  
treatment compared to those treated with the control DMSO were replotted from (F,G) and from (I,J) at 36	  
1 and 10 cd.s/m2 (denoted as 0 and 1 in the horizontal axis; (I)) or at all data points (K). Note that the 37	  
horizontal axes in (F-K) and the vertical axes in (I,K) are displayed in logarithmic scale. Asterisks; 38	  
statistically significant (p-value less than 0.05). The data are represented with the mean value ± s.e.m. 39	  
 40	  
	   19	  
Supplementary Figure S1 Toluidine blue staining of the samples for the EM images in Figure 1	  
2A-H. Semi-thin sections (1µm) of P20 mice stained with toluidine blue used for the analysis on a 2	  
transmission electron microscopy. Scale bar = 25 µm. 3	  
 4	  
Supplementary Figure S2 Photopic ERGs in the retinas treated with Fenretinide. The a-waves 5	  
(A,B) and b-waves (C,D) in C57BL/6xCBA/NSlc retinae were recorded under photopic conditions, as 6	  
in Figure 6. The gray arrows in (C) indicate the points where scores were too low and are not visible. 7	  
 8	  
Supplementary Table S1 Sequences for the qRT-PCR analysis 9	  
  10	  
	   20	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